We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Gold Nanoparticle Probes Identify Tumors Under the Skin

By MedImaging staff writers
Posted on 02 Jan 2008
Tiny gold particles embedded with dyes have been used to identify human tumors under the skin of a living animal. These nanoparticle probes may allow doctors to detect and diagnose cancer in man earlier and less invasively.

The gold particles described in a new study were linked with single chain variable fragment (ScFv) antibodies that recognize epidermal growth factor receptor (EGFR), which is present on the surface of many human tumors including head and neck and lung carcinomas. Covered with a non-toxic polymer, the gold particles are about 60-80 nanometers in diameter. That is 150 times smaller than a typical human cell and thousands of times smaller than a human hair. The antibody-linked particles accumulate in tumors ten times more than gold particles without antibodies.

In the study, which was led by Dr. Shuming Nie at the Emory-Georgia Tech Cancer Nanotechnology Center of Excellence (CCNE, Atlanta, GA, USA) the ScFv peptides bound cancer cells as the gold particles grasped human tumor cells after their injection into a mouse. When illuminated with a laser beam, the tumor-bound particles sent back a signal that is specific to the dye. The antibody-linked particles accumulated in tumors ten times more than gold particles without antibodies.

The results of the study appeared in the online journal Nature Biotechnology on December 23, 2007. In the article the scientists reported they are able to detect human cancer cells injected into a mouse at a depth of 1-2 cm. That makes the gold particles especially appropriate tools for gathering information about head or neck tumors, which tend to be more accessible.

Dr. Nie said that his lab plans to modify the coatings of the nanoparticles to improve tumor targeting. Eventually, he says, the gold particles could also be used to selectively deliver drugs to cancer cells.


Related Links:
Emory-Georgia Tech Cancer Nanotechnology Center of Excellence

New
High-Precision QA Tool
DEXA Phantom
Digital X-Ray Detector Panel
Acuity G4
40/80-Slice CT System
uCT 528
Portable Color Doppler Ultrasound System
S5000

Latest Nuclear Medicine News

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
02 Jan 2008  |   Nuclear Medicine

New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
02 Jan 2008  |   Nuclear Medicine

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
02 Jan 2008  |   Nuclear Medicine